Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

December 6, 2000

MOVA Pharmaceuticals Corporation Recalls Glyburide Tablets

Caguas, Puerto Rico (SafetyAlerts) - The Food and Drug Administration (FDA) said today that MOVA Pharmaceuticals Corporation is recalling certain glyburide tablets because some tablets are subpotent while others suffer from of blend uniformity non-conformance with RSD specification.

This is the first public notice of this Class III recall issued by FDA.

Glyburide Tablets, USP (micronized), Rx, indicated as an adjunct to diet to lower the blood glucose in patients with non-insulin-deptendent diabetes mellitus (Type II) whose hyperglycemia cannot be satisfactorily controlled by diet alone:

a) Glyburide Tablets, 6 mg, in 100-count bottles, NDC #55370-506-07 - Blend uniformity non-conformance with RSD specification.

b) Glyburide Tablets, 1.5 mg, in 100-count bottles, NDC #55370-146-07 - Subpotency.

Recall #D-050/051-1.

Lot Numbers: a) ST 43001A EXP 3/01; b) TT 2411A EXP 11/00.

MOVA Pharmaceuticals Corporation, Caguas, Puerto Rico.

Manufacturer, by letter dated October 16, 2000. Firm-initiated recall ongoing.


10,615 bottles were distributed.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers December 6, 2000.  For more information regarding the SafetyAlerts free email alert service please click here.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

SafetyAlerts compiles comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.